The use of single chain Fv as targeting agents for immunoliposomes: an update on immunoliposomal drugs for cancer treatment

Author： Cheng WW Allen TM

Publisher： Informa Healthcare

ISSN： 1742-5247

Source： Expert Opinion on Drug Delivery, Vol.7, Iss.4, 2010-04, pp. : 461-478

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis

By Kim E.J. Cho D. Hwang S.Y. Kim T.S.

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 608-615

Elsevier

Access to resources Recommend Favorite

A study of the use of drugs in the treatment of obesity among adult females

By Ezzat Sally

International Journal of Health Care Quality Assurance, Vol. 25, Iss. 8, 2012-09 ,pp. : 730-741

Emerald Group Publishing Ltd

Access to resources Recommend Favorite

Targeting anti-HIV drugs to the CNS

By Rao Kavitha S Ghorpade Anuja Labhasetwar Vinod

Expert Opinion on Drug Delivery, Vol. 6, Iss. 8, 2009-08 ,pp. : 771-784

Informa Healthcare

Access to resources Recommend Favorite

A comparison of peptide and folate receptor targeting of cancer cells: from single agent to nanoparticle

By Franzen Stefan

Expert Opinion on Drug Delivery, Vol. 8, Iss. 3, 2011-03 ,pp. : 281-298

Informa Healthcare

Access to resources Recommend Favorite

Modulation of Ras/ERK and Phosphoinositide Signaling by Long-Chain n-3 PUFA in Breast Cancer and Their Potential Complementary Role in Combination with Targeted Drugs

By Serini Simona Calviello Gabriella

Nutrients, Vol. 9, Iss. 3, 2017-02 ,pp. : 185-185

MDPI

Access to resources Recommend Favorite